Kestra Medical officer proposes selling 30,000 shares
Umberger's listed sales in the prior three months included 100,000 common shares on October 21, 2026, for $2,718,316.74.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Kestra Medical Technologies, Ltd. (KMTS) officer Traci Umberger gave notice of a proposed sale of 30,000 common shares, with an estimated aggregate market value of $900,880.51 and an approximate sale date of October 27, 2026. The shares are identified as arising from the exercise of employee stock options through a broker-assisted cashless exercise; Merrill Lynch is listed as broker.
Key Figures
Key Terms
Rule 144 regulatory
employee stock options financial
Broker assisted cashless exercise technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What prior KMTS sales by Traci Umberger are listed?
AI-generated analysis. How Rhea-AI works. Not financial advice.